Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression
Indira Mendez‐David(Inserm), Denis J. David(Inserm), Romain Colle(Inserm), Jean‐Philippe Guilloux(Inserm), Alain M. Gardier(Université Paris-Saclay), Emmanuelle Corruble(Inserm), Céline Boursier(Université Paris-Sud), Valérie Domergue(Université Paris-Sud), Bruno Falissard(Inserm)
Cited by 32
Related Papers
Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial
|The Lancet|2011|674
Complicated grief after death of a relative in the intensive care unit
|European Respiratory Journal|2015|359
Sample size requirements for the internal validation of psychiatric scales
|International Journal of Methods in Psychiatric Research|2011|298
Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions
|BMC Medicine|2012|284
KmL: k-means for longitudinal data
|Computational Statistics|2009|265